Fiduciary Trust’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
120,000
+40,000
| +50% | +$449K | 0.02% | 344 |
|
|
2025
Q1 | $366K | Buy |
80,000
+20,000
| +33% | +$91.4K | ﹤0.01% | 608 |
|
|
2024
Q4 | $338K | Buy |
60,000
+10,000
| +20% | +$56.4K | ﹤0.01% | 552 |
|
|
2024
Q3 | $242K | Buy |
50,000
+40,000
| +400% | +$194K | ﹤0.01% | 606 |
|
|
2024
Q2 | $48.8K | Hold |
10,000
| – | – | ﹤0.01% | 624 |
|
|
2024
Q1 | $133K | Hold |
10,000
| – | – | ﹤0.01% | 631 |
|
|
2023
Q4 | $139K | Buy |
+10,000
| New | +$139K | ﹤0.01% | 609 |
|